Targeted isoform-specific knockdown approaches, overexpression systems dissecting different components of RNA-toxicity, and RAN peptides using cell and animal models, may also provide useful insights into CTG18.1 expansion-mediated FECD disease mechanisms. The gene discussed is RAN; the disease is Fuchs endothelial corneal dystrophy.